Category for posts not assigned a category.
“Nan-Maree Schoerie elaborates on funding arrangement along with the plans for the company. ECS Botanics has added more than $100,000 into its accounts, thanks to a Victoria government manufacturing grant.” Watch video or read transcript on Ausbiz
“Nan-Maree Schoerie, Managing Director of ECS Botanics (ECS), discusses the fiscal performance of her company and her strategic plans to expand its market reach. Watch video or read transcript on Ausbiz
“Nan-Maree Schoerie, of ECS Botanics, reports the company’s revenue has seen a 78% surge. The outdoor cultivation area has grown by 60% and the firm has reported another quarter of positive net operating cash flow.” Watch video or read transcript on Ausbiz
“Nan-Maree Schoerie, from ECS Botanics (ECS), sheds light on the recent agreement with Elite Medical Solutions to retail its medicinal cannabis products.” Watch video or read transcript on Ausbiz
“ECS is launching a range of GMP-certified cannabidiol (CBD) and tetrahydrocannabinol (THC) pastilles and THC vapes.” Read full article on The Sentiment
“Amid optimism that cannabis’s ongoing slide will soon end, ASX-listed ECS Botanics has given an insight into why it defied the funk, to rise in 2023.” Read full article on the Australian Business Review
“Perth-headquartered medicinal cannabis company Little Green Pharma (LGP) is bullish on opportunities in Germany after the country legalised the drug on Friday with certain limitations, including personal possession of up to 25g, allowing three marijuana plants per household, and the establishment of non-commercial clubs for cultivation and distribution with caps on membership and volume.” Read…
“ECS Botanics Holdings, an Australian medical marijuana cultivator in Victoria, reported a significant jump in revenue to 7.3 million Australian dollars ($6.5 million) in its second fiscal quarter ending Dec. 31.” Read full article on MJBizDaily
“ECS Botanics Holdings (ASX:ECS) has inked a binding offtake agreement with UK-based Rokshaw for the supply of medicinal cannabis dried flower over the next three years.” Read full article on The Market Online
Introduction ECS Botanics Holding Ltd., a leading name in the organic cultivation and manufacturing of GMP medicinal cannabis products, recently hosted an insightful investor webinar. This event provided a comprehensive overview of the company’s operations, strategic initiatives, and future growth prospects. Here’s a detailed recap of the key points discussed during the webinar. Webinar Highlights…
2023/24 season update In 2023/24 ECS Botanics has been actively expanding its facilities and capabilities, demonstrating significant progress in both the cultivation and manufacturing of medicinal cannabis. This includes the continued strategic focus on using organic and regenerative agricultural practices to enhance product quality and environmental sustainability. Recent achievements and partnerships that ECS Botanics has…
On Tuesday, northern Victorian quiet achiever – the medicinal cannabis cultivator and manufacturer ECS Botanics (ASX:ECS) – revealed it secured a stunning five-year, $24 million deal to supply Perth-based MediCann Health with its top (medicinal cannabis dried flower) strain. The deal builds on the existing two-year contract and expects to deliver over four tonnes of dried cannabis flower…
ECS Botanics (ECS) has secured a $9.9 million supply agreement for medicinal cannabis products in Germany. The company entered a binding agreement with German company Ilios Santé GmbH for the supply of medicinal cannabis. Under the contract, ECS will exclusively supply four medicinal cannabis strains to Ilios Sante, with the first supply anticipated once product…
ECS Botanics Holdings Ltd (ASX:ECS) managing director Nan-Maree Schoerie brings Proactive’s Elisha Newell up to speed on the company’s value proposition ahead of the Peak Asset Management Microcap Conference on Thursday, July 13
ECS Botanics (ECS) has entered two offtake agreements worth a combined more than $11.9 million to supply medicinal cannabis dried flower in Australia. The company announced it will supply Melbourne-based Entoura with Good Manufacturing Practice (GMP) medicinal cannabis dried flower, worth $10.2 million over three years. Entoura supplies and develops high-quality medicinal cannabis products, but also…
Medicinal cannabis company, ECS Botanics (ECS) has launched the sale of two assets and secured a new loan facility. The company agreed to sell its hemp food and wellness business for $250,000 to Ananda Food, with contract completion expected in August upon the finalisation of due diligence. In addition, the company has planned to sell its…
ECS Botanics (ECS) has reached financial settlement of its Tasmanian medicinal cannabis business and assets for $3 million. The medicinal cannabis company agreed to sell its subsidiary, TasCo, which holds its Tasmanian operations and farm, to Blue Buffalo for $3 million. On October 24, the company announced to the market it had entered an unconditional…
Shares in ECS Botanics (ASX: ECS) rose by more than 22 per cent this morning after the Victorian medicinal cannabis grower and manufacturer announced its third supply contract win in just over three months, taking the total value of agreements reached since late June to $35.9 million.
